Chronic Pelvic Pain Syndrome Clinical Trial
Official title:
Long Term Effects of Pelvic Floor Re-education in Men With Chronic Pelvic Pain, Using Bio-feedback and Home Training - Subjective Outcomes in Correlation to Objective Measurements of the Lower Urinary Tract and Pelvic Floor
The goal of this randomized controlled study is to establish the long-term effect of pelvic floor re-education using biofeedback and home training for men with chronic pelvic pain. The main questions it aims to answer are if pelvic floor re-education using bio-feedback and home training will give a long-lasting improvement in symptoms, assessed with a validated symptom score (the National Institute of Health - Chronic Prostatitis Symptom Index) and if an improvement in symptoms can be correlated to objective measurements of pelvic floor function. Participants will be asked to do pelvic floor exercises daily during six months with additional sessions of bio-feedback training. The control group will have no changes in their on-going treatment for their chronic pelvic pain and will be offered to enter the treatment group after six months.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | December 2026 |
Est. primary completion date | December 2026 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Men over the age of 18, residents in Sweden, diagnosed with Chronic Primary Pelvic Pain Syndrome (CPPPS) according to the International Statistical Classification of Diseases and Related Health Problems (ICD-10) (N41.1 (chronic prostatitis), N41.9 (Inflammatory disease of prostate, unspecified), N50.8F (Chronic Pelvic Pain Syndrome in men) Exclusion Criteria: - Cancer in the abdomen or pelvic organs (current or previous) - Congenital anomalies affecting the pelvic region (Bladder exstrophy, Myelomeningocele etc.) - Transsexual male, (i.e. at birth biologically female) - Diseases affecting the nerve function to the pelvic and/or lower extremities, other disease or ongoing treatment that could have an impact on the outcome of the study. - Incapability to participate in testing or follow training instructions due to mental incapacity, language difficulties etc. |
Country | Name | City | State |
---|---|---|---|
Sweden | Karolinska University Hospital | Stockholm |
Lead Sponsor | Collaborator |
---|---|
Region Stockholm | Karolinska Institutet |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in symptom score on the National Institute of Health-Chronic Prostatitis Symptom Index questionnaire | Change in total score, range from 0-43 points. Higher score indicates worse symptoms. | Measured 3, 6 and 12 months after inclusion | |
Secondary | Change in sub score on the National Institute of Health-Chronic Prostatitis Symptom Index questionnaire | Sub score according to the domains; pain 0-21, urological symptoms 0-10 points and quality of life impact 0-12 points. Higher score indicates worse symptoms in all three domains. | Measured 3, 6 and 12 months after inclusion | |
Secondary | Changes in global voiding function using free flow non-invasive urodynamic testing | Changes in global voiding function using free flow non-invasive urodynamic testing with electromyogram.
Global assessment where combined results from maximum urinary flow rate, voided volume, post voiding residual volume, pelvic floor activity during voiding and the shape of the curve are used to define types of voiding patterns. Normal flow Asymmetrical obstructive flow Symmetrical low flow Irregular curve, straining flow Plateau low flow As described in the International Continence Society good urodynamic practices recommendations 2018 and Urodynamics (third edition) by P. Abrams. |
Measured 6 and 12 months after inclusion | |
Secondary | Changes in global storing function of the bladder using invasive urodynamics, cystometry | Changes in global bladder function using invasive urodynamics with cystometry with electromyogram.
Global assessment where combined results from sensory input, cystometric capacity, detrusor activity, compliance and pelvic floor activity are combined to define different patterns. Normal cystometry Abnormal sensory input Detrusor activity Abnormal compliance Abnormal bladder capacity As described in the International Continence Society good urodynamic practices recommendations 2018 and Urodynamics (third edition) by P. Abrams. |
Measured 6 and 12 months after inclusion | |
Secondary | Changes in global voiding function using invasive urodynamics, pressure-flow study | Changes in global voiding function using invasive urodynamics, pressure-flow study with electromyogram.
Global assessment where combined results from detrusor contractility, urinary flow and pelvic floor activity are combined to define different patterns. Normal flow Under-active flow Obstructed flow As described in the International Continence Society good urodynamic practices recommendations 2018 and Urodynamics (third edition) by P. Abrams. |
Measured 6 and 12 months after inclusion | |
Secondary | Changes in urethral pressure using invasive urodynamics, urethral pressure profile | Changes in urethral pressure using invasive urodynamics, urethral pressure profile.
Maximum urethral pressure (cmH2O) Maximum urethral closure pressure (cmH2O) As described in Urodynamics (third edition) by P. Abrams. |
Measured 6 and 12 months after inclusion | |
Secondary | Changes in pelvic floor muscle assessment according to test specifics by Frawley et al 2021 and the modified Oxford Scale according to Laycock et al 2001. | Pelvic floor muscle assessment according to test specifics by Frawley et al 2021
Assessment of muscle tone - Decreased / normal / increased Assessment of voluntary contraction - No contraction / correct contraction / contraction only with help from other muscles / uncertain / straining Assessment of relaxation post contraction - Yes / partial or delayed / no Assessment of tenderness Yes / No If yes location is noted and severity of pain is graded according to numeric rating scale, 0-10, with higher value indicatinge more severe pain. Modified Oxford Scale for assessment of pelvic floor muscle power, graded from 0-5 with higer value indicating stronger power. |
Measured 3, 6 and 12 months after inclusion | |
Secondary | Correlation between subjective and objective measurements | Correlation between subjective measurements using the National Institute of Health-Chronic Prostatitis Symptom Index questionnaire and objective findings on urodynamic testing and pelvic floor assessment. | Measured 3, 6 and 12 months after inclusion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05868668 -
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
|
N/A | |
Completed |
NCT05546203 -
Trigger Point Treatment in Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT05926752 -
Photobiomodulation for Myofascial Pelvic Pain
|
N/A | |
Completed |
NCT00775281 -
Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.
|
N/A | |
Recruiting |
NCT06209346 -
Multimodal Physiotherapy Based on Tele-rehabilitation in Chronic Pelvic Pain Associated With Endometriosis
|
N/A | |
Terminated |
NCT01879930 -
Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study
|
Phase 4 | |
Completed |
NCT00688506 -
Combined Sono-electro-magnetic Therapy for Treatment of Refractory Chronic Pelvic Pain Syndrome
|
N/A | |
Completed |
NCT00922012 -
Efficacy of Electromagnetic Stimulation Therapy for Chronic Prostatitis and Chronic Pelvic Pain Syndrome
|
N/A | |
Completed |
NCT00434343 -
Physical Therapy Trial for Pelvic Pain
|
N/A | |
Recruiting |
NCT03641807 -
Different Modes of Assessment on Acupuncture Effect on Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
|
N/A | |
Completed |
NCT00710073 -
Sono-Electro-Magnetic Therapy for Refractory Chronic Pelvic Pain Syndrome
|
N/A | |
Completed |
NCT01843946 -
Clinical Efficacy of Roxithromycin in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
|
N/A | |
Completed |
NCT04549389 -
The Ideal LiST Session Frequency Protocol for CPPS Treatment
|
N/A | |
Recruiting |
NCT06161805 -
Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study
|
Phase 3 | |
Not yet recruiting |
NCT06168058 -
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
|
N/A | |
Completed |
NCT01738464 -
Microbiomes of Pelvic Pain
|
||
Completed |
NCT01391338 -
A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)
|
Phase 2 | |
Not yet recruiting |
NCT06445790 -
Efficacy of Cognitive Behavior Therapy in the Treatment of Chronic Pelvic Pain in Women
|
N/A | |
Recruiting |
NCT05754190 -
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
|
||
Completed |
NCT06038773 -
Social and Clinical Aspects of Pelvic Pain in Turkey
|